Managing Hypertension in Addison's Disease
When hypertension develops in a patient with Addison's disease on replacement therapy, first reduce the fludrocortisone dose, and if blood pressure remains elevated, add an ACE inhibitor or angiotensin II receptor blocker while continuing fludrocortisone. 1
Step-by-Step Management Algorithm
Step 1: Evaluate Both Glucocorticoid and Mineralocorticoid Replacement
Assess for over-replacement of either medication, as both can cause hypertension. 1
- Glucocorticoid assessment: Look for signs of excess including weight gain, central adiposity, insomnia, and peripheral edema 1, 2
- Mineralocorticoid assessment: Check for edema, measure sitting and standing blood pressure, and assess volume status 1
- Laboratory evaluation: Measure serum electrolytes and consider plasma renin activity 1
The Endocrine Society guidelines emphasize that overtreatment with either hydrocortisone or fludrocortisone can lead to hypertension, making this initial assessment critical. 1
Step 2: Reduce Fludrocortisone Dose First
If clinical or biochemical signs of mineralocorticoid excess are present (edema, suppressed renin), reduce fludrocortisone from the typical 0.1 mg daily down to 0.05 mg daily. 1, 3
- The FDA label specifically recommends dose reduction to 0.05 mg daily when transient hypertension develops 3
- Some patients may require complete withdrawal of fludrocortisone if hypertension is severe 4, 5
- Monitor blood pressure response over 1-2 weeks after dose adjustment 1
Important caveat: If plasma renin activity is in the upper normal range or elevated (indicating adequate to insufficient mineralocorticoid replacement), do not reduce fludrocortisone further. 4
Step 3: Add Antihypertensive Medication if Needed
If hypertension persists after optimizing replacement doses and the patient is euvolemic, initiate an ACE inhibitor or angiotensin II receptor blocker as first-line therapy. 1, 4
- These agents counter the vasoconstrictive effects of elevated angiotensin II that may persist despite adequate replacement 1
- Continue fludrocortisone at the appropriate dose based on clinical assessment and renin levels 1, 4
- Second-line option: Dihydropyridine calcium channel blockers can be added if needed 1
Critical Medications to Avoid
Never use the following in Addison's disease patients: 1, 4
- Diuretics should be avoided as they can precipitate adrenal crisis 1
- Aldosterone receptor blockers (spironolactone, eplerenone) are absolutely contraindicated 1
Understanding the Paradox
A key clinical insight is that hypertension can coexist with Addison's disease despite the typical association of adrenal insufficiency with hypotension. 1 Research shows that some patients develop hypertension even with elevated plasma renin activity and reduced plasma volume, suggesting that normalization of volume status through aggressive fludrocortisone dosing may not be appropriate if it causes hypertension. 5
Primary (essential) hypertension can also occur independently in patients with Addison's disease, requiring standard antihypertensive management while maintaining appropriate hormone replacement. 1
Monitoring Parameters
- Blood pressure: Measure both sitting and standing at each visit 1
- Electrolytes: Check sodium and potassium periodically 1, 3
- Plasma renin activity: Target upper normal range as a marker of adequate mineralocorticoid replacement 1, 4
- Clinical symptoms: Assess for salt craving, orthostatic symptoms, or edema 1
Common Pitfalls to Avoid
- Do not use ACTH levels to guide glucocorticoid dosing, as this leads to over-replacement 1
- Do not normalize plasma renin activity to low-normal levels if this requires excessive fludrocortisone and causes hypertension 4, 5
- Do not stop fludrocortisone entirely in most cases unless heart failure is present, as aldosterone deficiency still requires replacement 1, 4
- Avoid substances that potentiate mineralocorticoid effects: Licorice and grapefruit juice should be avoided 1